Akram Alnounou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Akram Alnounou has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
Eric Martin Sieloff
Department of Internal Medicine, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, USA
4 shared publications- Arghyadeep Ganguly
Department of Internal Medicine Western Michigan University Homer Stryker MD School of Medicine Kalamazoo Michigan USA
3 shared publications - Bisher Sawaf
Department of Internal Medicine University of Toledo Toledo Ohio USA
3 shared publications Henry Zou
Western Michigan University Homer Stryker MD School of Medicine
3 shared publications- Mohammad Alabbas
Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic, Cleveland, USA
3 shared publications Neil Hughes
Western Michigan University Homer Stryker MD School of Medicine
3 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by Wiley in JPGN Reports
Severe constipation‐associated postprandial abdominal pain in a pregnant native‐liver biliary atresia survivor after Kasai portoenterostomy: A case report
An 18‐year‐old woman with congenital biliary atresia status post Kasai portoenterostomy and magnetic resonance imaging‐reported chronic liver disease presented at 32 weeks’ gestation with 6 weeks of worsening postprandial epigastric/right upper quadrant pain, nausea, and poor oral intake. Evaluation showed preserved hepatic synthetic function and no demonstrated clinically significant portal hypertension. Endoscopy excluded esophageal and gastric varices, computed tomography showed no imaging evidence of pancreatitis, biliary obstruction, or other acute intra‐abdominal pathology, computed tomography angiography excluded mesenteric ischemia, and gastric emptying scintigraphy excluded gastroparesis. Nonreassuring fetal surveillance prompted preterm induction at approximately 33 weeks 4 days. Postpartum symptoms persisted, and imaging review identified severe constipation with rectal impaction/fecalization as the dominant treatable contributor. This case broadens the peripartum phenotype reported in native‐liver biliary atresia survivors by emphasizing constipation‐associated postprandial abdominal pain, poor oral intake, nutritional risk, and medication‐related bowel dysfunction rather than variceal bleeding or hepatic decompensation alone.
- 14 October 2026
- Published by Wiley in JPGN Reports
Open AccessSevere constipation‐associated postprandial abdominal pain in a pregnant native‐liver biliary atresia survivor after Kasai portoenterostomy: A case report
An 18‐year‐old woman with congenital biliary atresia status post Kasai portoenterostomy and magnetic resonance imaging‐reported chronic liver disease presented at 32 weeks’ gestation with 6 weeks of worsening postprandial epigastric/right upper quadrant pain, nausea, and poor oral intake. Evaluation showed preserved hepatic synthetic function and no demonstrated clinically significant portal hypertension. Endoscopy excluded esophageal and gastric varices, computed tomography showed no imaging evidence of pancreatitis, biliary obstruction, or other acute intra‐abdominal pathology, computed tomography angiography excluded mesenteric ischemia, and gastric emptying scintigraphy excluded gastroparesis. Nonreassuring fetal surveillance prompted preterm induction at approximately 33 weeks 4 days. Postpartum symptoms persisted, and imaging review identified severe constipation with rectal impaction/fecalization as the dominant treatable contributor. This case broadens the peripartum phenotype reported in native‐liver biliary atresia survivors by emphasizing constipation‐associated postprandial abdominal pain, poor oral intake, nutritional risk, and medication‐related bowel dysfunction rather than variceal bleeding or hepatic decompensation alone.
- Open Access
- 1 October 2026
- Published by Frontiers Media SA in Frontiers in Gastroenterology
- Vol. 5, 1728396
Case Report: Lithium-induced bradycardia triggered by cecal volvulus: a case of obstruction-associated drug accumulation
Background: Lithium toxicity can rarely manifest as cardiac arrhythmias, often initially presenting as bradycardia. Bowel obstruction is a rare cause of acute lithium toxicity. We present a case of lithium-induced symptomatic bradycardia induced by cecal volvulus. Case report: An 84-year-old female with a history of bipolar 1 disorder on chronic lithium therapy was admitted for symptomatic bradycardia and abdominal pain. She also presented with myoclonus, polydipsia, and encephalopathy. Laboratory evaluation revealed lithium toxicity in the setting of renal impairment, and abdominal imaging findings indicated large bowel obstruction secondary to cecal volvulus. Lithium was discontinued, and the patient was managed supportively. Despite declining lithium levels, the patient’s symptomatic bradycardia persisted until surgical correction of the volvulus, after which cardiac and neurological function markedly improved. Significance: This case highlights the potential role of gastrointestinal obstruction in exacerbating lithium-induced bradycardia by impairing its clearance and inducing a vagal response triggered by abdominal distension.
- 1 October 2026
- Published by Frontiers Media SA in Frontiers in Gastroenterology
- Vol. 5, 1728396
Open AccessCase Report: Lithium-induced bradycardia triggered by cecal volvulus: a case of obstruction-associated drug accumulation
Background: Lithium toxicity can rarely manifest as cardiac arrhythmias, often initially presenting as bradycardia. Bowel obstruction is a rare cause of acute lithium toxicity. We present a case of lithium-induced symptomatic bradycardia induced by cecal volvulus. Case report: An 84-year-old female with a history of bipolar 1 disorder on chronic lithium therapy was admitted for symptomatic bradycardia and abdominal pain. She also presented with myoclonus, polydipsia, and encephalopathy. Laboratory evaluation revealed lithium toxicity in the setting of renal impairment, and abdominal imaging findings indicated large bowel obstruction secondary to cecal volvulus. Lithium was discontinued, and the patient was managed supportively. Despite declining lithium levels, the patient’s symptomatic bradycardia persisted until surgical correction of the volvulus, after which cardiac and neurological function markedly improved. Significance: This case highlights the potential role of gastrointestinal obstruction in exacerbating lithium-induced bradycardia by impairing its clearance and inducing a vagal response triggered by abdominal distension.
- Open Access
- 24 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (19) , 7437
Implementation of a Multidisciplinary Rounding Tool in a Medical Intensive Care Unit and Its Association with Rounding Efficiency and Multidisciplinary Collaboration
Background: Multidisciplinary rounds are essential for high-quality intensive care but are frequently hindered by inconsistent team participation and logistical inefficiencies. We evaluated the associated impact of implementing a standardized multidisciplinary rounding checklist and real-time paging system on multidisciplinary team attendance, rounding efficiency, and selected clinical outcomes in the ICU. Methods: A retrospective, observational pre- and post-intervention cohort study featuring a concurrent control group was conducted at a tertiary care hospital. The study included 331 adults admitted to the medical ICU (MICU) and neurovascular critical care unit (NCCU; control). The intervention combined a standardized rounding checklist incorporating the ICU Liberation (ABCDEF) bundle and FAST HUGS BID mnemonic with a real-time paging notification system to alert team members of round start times and locations. The primary outcome was change in multidisciplinary team participation at the start and end of rounds; secondary outcomes included rounding time per patient and exploratory care-process outcomes. Results: Multidisciplinary participation at the start and conclusion of rounds significantly improved for both the MICU advanced practice provider (APP) team (p = 0.003 and p = 0.002, respectively) and the resident team (p = 0.006 and p < 0.001, respectively), while attendance in the NCCU group remained unchanged. Median rounding time per patient decreased by 20.8% (13.0 to 10.3 min, p < 0.001). In a survivor-only sensitivity analysis, the streamlined workflow decreased the median time to physical and occupational therapy consultations from 4 to 2 days (p ≤ 0.002). Invasive device stewardship significantly improved; central venous catheter utilization decreased from 58.0% to 25.0% (p < 0.001), and arterial line utilization fell from 55.0% to 26.5% (p < 0.001), with median arterial catheter duration decreasing from 5 to 3 days (p = 0.001). Conclusions: Implementing low-cost, reliable workflow standardization tools was associated with significantly improved multidisciplinary participation and shorter rounding time per patient. Favorable changes in selected care-process measures were also observed, although patient-level clinical outcomes should be interpreted as exploratory and future studies are warranted.
- 24 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (19) , 7437
Open AccessImplementation of a Multidisciplinary Rounding Tool in a Medical Intensive Care Unit and Its Association with Rounding Efficiency and Multidisciplinary Collaboration
Background: Multidisciplinary rounds are essential for high-quality intensive care but are frequently hindered by inconsistent team participation and logistical inefficiencies. We evaluated the associated impact of implementing a standardized multidisciplinary rounding checklist and real-time paging system on multidisciplinary team attendance, rounding efficiency, and selected clinical outcomes in the ICU. Methods: A retrospective, observational pre- and post-intervention cohort study featuring a concurrent control group was conducted at a tertiary care hospital. The study included 331 adults admitted to the medical ICU (MICU) and neurovascular critical care unit (NCCU; control). The intervention combined a standardized rounding checklist incorporating the ICU Liberation (ABCDEF) bundle and FAST HUGS BID mnemonic with a real-time paging notification system to alert team members of round start times and locations. The primary outcome was change in multidisciplinary team participation at the start and end of rounds; secondary outcomes included rounding time per patient and exploratory care-process outcomes. Results: Multidisciplinary participation at the start and conclusion of rounds significantly improved for both the MICU advanced practice provider (APP) team (p = 0.003 and p = 0.002, respectively) and the resident team (p = 0.006 and p < 0.001, respectively), while attendance in the NCCU group remained unchanged. Median rounding time per patient decreased by 20.8% (13.0 to 10.3 min, p < 0.001). In a survivor-only sensitivity analysis, the streamlined workflow decreased the median time to physical and occupational therapy consultations from 4 to 2 days (p ≤ 0.002). Invasive device stewardship significantly improved; central venous catheter utilization decreased from 58.0% to 25.0% (p < 0.001), and arterial line utilization fell from 55.0% to 26.5% (p < 0.001), with median arterial catheter duration decreasing from 5 to 3 days (p = 0.001). Conclusions: Implementing low-cost, reliable workflow standardization tools was associated with significantly improved multidisciplinary participation and shorter rounding time per patient. Favorable changes in selected care-process measures were also observed, although patient-level clinical outcomes should be interpreted as exploratory and future studies are warranted.
- 15 August 2026
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 71 (11) , 5899-5912
Upper Versus Lower Gastrointestinal Bleeding in Percutaneous Coronary Intervention Hospitalizations: A National Analysis, 2016–2022
- 15 August 2026
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 71 (11) , 5899-5912
Upper Versus Lower Gastrointestinal Bleeding in Percutaneous Coronary Intervention Hospitalizations: A National Analysis, 2016–2022
- 10 August 2026
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 39 (6) , 1030-1042
Palliative care documentation in gastrointestinal bleeding hospitalizations: national trends and associated care patterns
- 10 August 2026
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 39 (6) , 1030-1042
Palliative care documentation in gastrointestinal bleeding hospitalizations: national trends and associated care patterns
- Open Access
- 1 August 2026
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 13 (8)
Giant Mature Cystic Perihepatic Teratoma in an Adult Woman
Perihepatic teratomas are exceedingly rare extragonadal germ cell tumors that may mimic more common hepatic cystic lesions on imaging. We report a 38-year-old woman with several months of abdominal bloating and early satiety. Laboratory studies and tumor markers (α-fetoprotein and carcinoembryonic antigen) were unremarkable. Magnetic resonance imaging demonstrated a 17.7 cm complex cystic lesion adjacent to the left hepatic lobe with fatty components and a mural nodule. Elective laparotomy revealed a well-encapsulated mass arising from the lesser omentum, excised intact. Histopathology confirmed a mature cystic teratoma with elements from all 3 germ layers. The postoperative course was uneventful.
- 1 August 2026
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 13 (8)
Open AccessGiant Mature Cystic Perihepatic Teratoma in an Adult Woman
Perihepatic teratomas are exceedingly rare extragonadal germ cell tumors that may mimic more common hepatic cystic lesions on imaging. We report a 38-year-old woman with several months of abdominal bloating and early satiety. Laboratory studies and tumor markers (α-fetoprotein and carcinoembryonic antigen) were unremarkable. Magnetic resonance imaging demonstrated a 17.7 cm complex cystic lesion adjacent to the left hepatic lobe with fatty components and a mural nodule. Elective laparotomy revealed a well-encapsulated mass arising from the lesser omentum, excised intact. Histopathology confirmed a mature cystic teratoma with elements from all 3 germ layers. The postoperative course was uneventful.
- Open Access
- 16 July 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1825538
Disseminated Nocardia farcinica with multiple cerebral abscesses in a patient receiving induction immunosuppression for autoimmune hepatitis: case report
Background: Nocardiosis is an opportunistic infection caused by aerobic, Gram-positive actinomycetes of the genus Nocardia that most often affects patients with impaired cell-mediated immunity, including those receiving corticosteroids or other immunosuppressive therapies. Disseminated disease frequently involves the central nervous system, where a systematic review reported an overall case fatality rate of 22.8%, and Nocardia farcinica is the most commonly identified species. We report a case of disseminated Nocardia farcinica with multiple cerebral abscesses in a patient receiving induction immunosuppressive therapy for autoimmune hepatitis. Case report: A 55-year-old man with a history of autoimmune hepatitis and occupational soil exposure presented with 4–5 week history of progressive cognitive impairment, dysarthria, and right upper extremity weakness. Two months earlier, he had been treated with high-dose corticosteroids and azathioprine and prescribed trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis, which had been interrupted for an estimated 2–4 weeks before presentation during ongoing corticosteroid therapy. Upon admission, laboratory tests demonstrated neutrophil-predominant leukocytosis with lymphopenia, and liver function tests showed substantial improvement compared to his initial presentation of autoimmune hepatitis. Neuroimaging revealed multiple ring-enhancing intracerebral lesions with surrounding vasogenic edema. Stereotactic aspiration of a cerebral abscess and drainage of a concurrent retroperitoneal collection grew Nocardia farcinica , confirming disseminated nocardiosis. Antimicrobial therapy was transitioned to imipenem-cilastatin and TMP-SMX based on susceptibility testing. During infection management, azathioprine was paused, and prednisone was continued at a dose of 25 mg/day, followed by a biochemical autoimmune hepatitis flare requiring hepatology-guided monitoring. The patient demonstrated gradual neurologic improvement and was discharged to inpatient rehabilitation after an 18-day hospitalization. Conclusion: Disseminated nocardiosis should be considered for immunosuppressed patients with autoimmune hepatitis presenting with subacute neurological decline and ring-enhancing brain lesions, particularly during outpatient immunosuppression transitions when antimicrobial prophylaxis may be interrupted or incompletely reconciled. The patient demonstrated progressive neurological improvement and radiographic abscess reduction after 3 months of susceptibility-guided combination therapy, reinforcing the importance of early tissue diagnosis and neurosurgical intervention in this population.
- 16 July 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1825538
Open AccessDisseminated Nocardia farcinica with multiple cerebral abscesses in a patient receiving induction immunosuppression for autoimmune hepatitis: case report
Background: Nocardiosis is an opportunistic infection caused by aerobic, Gram-positive actinomycetes of the genus Nocardia that most often affects patients with impaired cell-mediated immunity, including those receiving corticosteroids or other immunosuppressive therapies. Disseminated disease frequently involves the central nervous system, where a systematic review reported an overall case fatality rate of 22.8%, and Nocardia farcinica is the most commonly identified species. We report a case of disseminated Nocardia farcinica with multiple cerebral abscesses in a patient receiving induction immunosuppressive therapy for autoimmune hepatitis. Case report: A 55-year-old man with a history of autoimmune hepatitis and occupational soil exposure presented with 4–5 week history of progressive cognitive impairment, dysarthria, and right upper extremity weakness. Two months earlier, he had been treated with high-dose corticosteroids and azathioprine and prescribed trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis, which had been interrupted for an estimated 2–4 weeks before presentation during ongoing corticosteroid therapy. Upon admission, laboratory tests demonstrated neutrophil-predominant leukocytosis with lymphopenia, and liver function tests showed substantial improvement compared to his initial presentation of autoimmune hepatitis. Neuroimaging revealed multiple ring-enhancing intracerebral lesions with surrounding vasogenic edema. Stereotactic aspiration of a cerebral abscess and drainage of a concurrent retroperitoneal collection grew Nocardia farcinica , confirming disseminated nocardiosis. Antimicrobial therapy was transitioned to imipenem-cilastatin and TMP-SMX based on susceptibility testing. During infection management, azathioprine was paused, and prednisone was continued at a dose of 25 mg/day, followed by a biochemical autoimmune hepatitis flare requiring hepatology-guided monitoring. The patient demonstrated gradual neurologic improvement and was discharged to inpatient rehabilitation after an 18-day hospitalization. Conclusion: Disseminated nocardiosis should be considered for immunosuppressed patients with autoimmune hepatitis presenting with subacute neurological decline and ring-enhancing brain lesions, particularly during outpatient immunosuppression transitions when antimicrobial prophylaxis may be interrupted or incompletely reconciled. The patient demonstrated progressive neurological improvement and radiographic abscess reduction after 3 months of susceptibility-guided combination therapy, reinforcing the importance of early tissue diagnosis and neurosurgical intervention in this population.
- Open Access
- 1 July 2026
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 13 (7) , e02236
Stress-Induced (Takotsubo) Cardiomyopathy Associated With Upadacitinib Induction Therapy in Severe Crohn's Disease
Janus kinase inhibitors (JAKi) carry a class-wide boxed warning for major adverse cardiovascular events; however, stress-induced cardiomyopathy has not been previously reported with upadacitinib. A 64-year-old woman with Crohn's disease and high-output ileostomy was initiated on upadacitinib 45 mg daily. Six days later, she developed new left ventricular systolic dysfunction (ejection fraction 35%) with mid-to-apical wall motion abnormalities. Coronary angiography showed nonobstructive disease, and cardiac magnetic resonance imaging demonstrated normalization of biventricular function without fibrosis or infarction, consistent with Takotsubo cardiomyopathy. Naranjo scoring indicated a possible adverse drug reaction (score 3). This first reported case of Takotsubo cardiomyopathy temporally associated with upadacitinib, alongside previous reports with tofacitinib and ruxolitinib, suggests a potential JAKi class-related cardiac effect. Clinicians should maintain a low threshold for cardiac evaluation in patients who develop dyspnea, edema, arrhythmias, or unexplained hemodynamic instability soon after JAKi initiation, particularly when substantial physical stressors or cardiovascular risk factors are present.
- 1 July 2026
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 13 (7) , e02236
Open AccessStress-Induced (Takotsubo) Cardiomyopathy Associated With Upadacitinib Induction Therapy in Severe Crohn's Disease
Janus kinase inhibitors (JAKi) carry a class-wide boxed warning for major adverse cardiovascular events; however, stress-induced cardiomyopathy has not been previously reported with upadacitinib. A 64-year-old woman with Crohn's disease and high-output ileostomy was initiated on upadacitinib 45 mg daily. Six days later, she developed new left ventricular systolic dysfunction (ejection fraction 35%) with mid-to-apical wall motion abnormalities. Coronary angiography showed nonobstructive disease, and cardiac magnetic resonance imaging demonstrated normalization of biventricular function without fibrosis or infarction, consistent with Takotsubo cardiomyopathy. Naranjo scoring indicated a possible adverse drug reaction (score 3). This first reported case of Takotsubo cardiomyopathy temporally associated with upadacitinib, alongside previous reports with tofacitinib and ruxolitinib, suggests a potential JAKi class-related cardiac effect. Clinicians should maintain a low threshold for cardiac evaluation in patients who develop dyspnea, edema, arrhythmias, or unexplained hemodynamic instability soon after JAKi initiation, particularly when substantial physical stressors or cardiovascular risk factors are present.
- Open Access
- 26 June 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1877827
Mechanism-matched Helicobacter pylori treatment in the potassium-competitive acid blocker era
Helicobacter pylori infection remains common worldwide and causes chronic gastritis, peptic ulcer disease, gastric mucosa-associated lymphoid tissue lymphoma, and gastric cancer. Eradication therapy has become less reliable as resistance to clarithromycin, metronidazole, and levofloxacin has reduced the performance of older empiric regimens. Potassium-competitive acid blockers (P-CABs), molecular resistance testing, fecal susceptibility assays, and new antimicrobial strategies have changed treatment selection, but none removes the need to match regimen design to microbial biology and antibiotic activity. This narrative review argues that H. pylori management is shifting from empiric eradication toward mechanism-matched therapy. The framework links gastric niche biology, acid acclimation, adhesion, virulence signaling, immune evasion, resistance mechanisms, acid suppression, and partner-antibiotic selection. Recent randomized trials show the strengths and limits of this approach. Vonoprazan-based regimens improve acid suppression and can outperform proton pump inhibitor-based triple therapy in clarithromycin-resistant infection, but rescue-treatment trials show that potent acid suppression alone is insufficient when the partner antibiotic is poorly matched. Molecular testing-guided therapy and fecal molecular susceptibility testing provide practical ways to align antibiotic selection with resistance mechanisms. Rifasutenizol adds a pathogen-targeted option supported by phase 3 evidence in treatment-naive Chinese patients. Adjunctive and investigational approaches, including probiotics, vaccines, phytochemicals, phage-derived agents, and nanomedicine, should be interpreted as supportive or developmental strategies rather than replacements for validated antimicrobial regimens. A mechanism-matched approach can help clinicians and investigators choose regimens, interpret trial results, and design studies that distinguish failures caused by resistance, inadequate acid suppression, regimen intolerance, and prior antibiotic exposure.
- 26 June 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1877827
Open AccessMechanism-matched Helicobacter pylori treatment in the potassium-competitive acid blocker era
Helicobacter pylori infection remains common worldwide and causes chronic gastritis, peptic ulcer disease, gastric mucosa-associated lymphoid tissue lymphoma, and gastric cancer. Eradication therapy has become less reliable as resistance to clarithromycin, metronidazole, and levofloxacin has reduced the performance of older empiric regimens. Potassium-competitive acid blockers (P-CABs), molecular resistance testing, fecal susceptibility assays, and new antimicrobial strategies have changed treatment selection, but none removes the need to match regimen design to microbial biology and antibiotic activity. This narrative review argues that H. pylori management is shifting from empiric eradication toward mechanism-matched therapy. The framework links gastric niche biology, acid acclimation, adhesion, virulence signaling, immune evasion, resistance mechanisms, acid suppression, and partner-antibiotic selection. Recent randomized trials show the strengths and limits of this approach. Vonoprazan-based regimens improve acid suppression and can outperform proton pump inhibitor-based triple therapy in clarithromycin-resistant infection, but rescue-treatment trials show that potent acid suppression alone is insufficient when the partner antibiotic is poorly matched. Molecular testing-guided therapy and fecal molecular susceptibility testing provide practical ways to align antibiotic selection with resistance mechanisms. Rifasutenizol adds a pathogen-targeted option supported by phase 3 evidence in treatment-naive Chinese patients. Adjunctive and investigational approaches, including probiotics, vaccines, phytochemicals, phage-derived agents, and nanomedicine, should be interpreted as supportive or developmental strategies rather than replacements for validated antimicrobial regimens. A mechanism-matched approach can help clinicians and investigators choose regimens, interpret trial results, and design studies that distinguish failures caused by resistance, inadequate acid suppression, regimen intolerance, and prior antibiotic exposure.